DURABLE REMISSIONS WITH CONTROL OF CYTOKINE RELEASE SYNDROME (CRS) USING T CELLS EXPRESSING CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) CTL019 TO TREAT RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOID LEUKEMIA (ALL)

被引：1

作者：

Levine, B. L. ^{[1
,2
,3
]}

Maude, S. ^{[4
,5
,6
]}

Zheng, Z. ^{[1
,2
]}

Shaw, P. ^{[7
]}

Ambrose, D. ^{[1
]}

Aplenc, R. ^{[5
,6
]}

Barker, C. ^{[4
,5
,6
]}

Barrett, D. ^{[4
,5
,6
]}

Brogdon, J. ^{[8
]}

Callahan, C. ^{[5
,6
]}

Chen, F. ^{[1
]}

Chew, A. ^{[1
]}

Davis, M. M. Suhoski ^{[1
,2
]}

Fesnak, A. D. ^{[1
,2
]}

Finklestein, J. ^{[1
]}

Frey, N. ^{[8
]}

Lacey, S. ^{[1
]}

Lamontagne, A. ^{[1
,2
]}

Lewitt, L. ^{[1
,2
]}

Loew, A. ^{[8
]}

Marcucci, K. ^{[1
]}

Melenhorst, J. ^{[1
,2
]}

Motley, L. ^{[5
,6
]}

Mudambi, M. ^{[5
,6
]}

Nazimuddin, F. ^{[1
]}

O'Rourke, M. ^{[1
,2
]}

Porter, D. ^{[3
]}

Rheingold, S. R. ^{[5
,6
]}

Scholler, J. ^{[1
]}

Tayor, C. ^{[1
,2
]}

White, C. ^{[5
,6
]}

Wood, P. ^{[9
]}

Young, R. ^{[1
]}

Teachey, D. T. ^{[4
,5
,6
]}

June, C. ^{[1
,2
,3
]}

Grupp, S. ^{[3
,4
,5
,6
]}

机构：

[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA

[2] Univ Penn, Pathol & Lab Med, Philadelphia, PA 19104 USA

[3] Abramson Canc Ctr, Philadelphia, PA USA

[4] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA

[5] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

[6] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA

[7] Univ Penn, Biostat & Epidemiol, Philadelphia, PA 19104 USA

[8] Novartis Inst Biomed Res, Cambridge, MA USA

[9] Novartis Pharmaceut, Cell & Gene Therapies Unit, E Hanover, NJ USA

来源：

CYTOTHERAPY | 2016年 / 18卷 / 06期

关键词：

D O I：

10.1016/j.jcyt.2016.03.039

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

引用

页码：S14 / S15

页数：2

共 50 条

[1] Durable remissions, with control and prediction of cytokine release syndrome (CRS), using T cells expressing a CD19-targeted chimeric antigen receptor (CTL019) to treat relapsed/refractory (r/r) pediatric ALL
Grupp, S.
Maude, S.
Shaw, P. A.
Aplenc, R.
Barker, C.
Barrett, D. M.
Callahan, C.
Chen, F.
Finklestein, J.
Frey, N.
Lacey, S. F.
Levine, B. L.
Melenhorst, J. J.
Motley, L.
Nazimuddin, F.
Porter, D.
Rheingold, S. R.
White, C.
Wood, P. A.
Zheng, Z.
Teachey, D. T.
June, C.
BONE MARROW TRANSPLANTATION, 2016, 51 : S321 - S322
[2] Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)
Grupp, Stephan A.
Maude, Shannon L.
Shaw, Pamela A.
Aplenc, Richard
Barrett, David M.
Callahan, Colleen
Lacey, Simon F.
Levine, Bruce L.
Melenhorst, J. Joseph
Motley, Laura
Rheingold, Susan R.
Teachey, David T.
Wood, Patricia A.
Porter, David
June, Carl H.
BLOOD, 2015, 126 (23)
[3] T Cells Engineered with a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Have Long Term Persistence and Induce Durable Remissions in Children with Relapsed, Refractory ALL
Grupp, Stephan A.
Maude, Shannon L.
Shaw, Pamela
Aplenc, Richard
Barrett, David M.
Callahan, Colleen
Chew, Anne
Lacey, Simon F.
Levine, Bruce L.
Melenhorst, J. Joseph
Motley, Laura
Rheingold, Susan R.
Shen, Angela
Teachey, David T.
Wood, Patricia A.
Porter, David L.
June, Carl H.
BLOOD, 2014, 124 (21)
[4] Sustained Remissions Following Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed or Refractory CD19+Lymphomas
Schuster, Stephen J.
Svoboda, Jakub
Nasta, Sunita Dwivedy
Porter, David L.
Chong, Elise A.
Landsburg, Daniel J.
Mato, Anthony R.
Lacey, Simon F.
Melenhorst, Jan J.
Chew, Anne
Hasskarl, Jens
Shah, Gaurav D.
Wasik, Mariusz A.
Marcucci, Katherine T.
Zheng, Zhaohui
Levine, Bruce L.
June, Carl H.
BLOOD, 2015, 126 (23)
[5] Chimeric Antigen Receptor (CAR)-Modified T Cells (CTL019) Induce Durable CNS Remissions in Children with CNS/Combined Bone Marrow and CNS Relapsed/Refractory CD19+Acute Lymphoblastic Leukemia
Talekar, Mala
Hucks, George
Maude, Shannon
Kawchak, Nicholas
Motley, Laura
Barrett, David
Lacey, Simon
Levine, Bruce
Melenhorst, Jan
Shaw, Pamela
Callahan, Colleen
White, Claire
Barker, Christine
Baniewicz, Diane
Duckworth, Mark
Aplenc, Richard
Teachey, David
June, Carl
Grupp, Stephan
Rheingold, Susan
PEDIATRIC BLOOD & CANCER, 2017, 64 : S2 - S2
[6] Cellular Kinetics of Chimeric Antigen Receptor T Cells (CTL019) in Patients with Relapsed/Refractory CD19+Leukemia
Mueller, Karen Thudium
Chakraborty, Abhijit
Wood, Patricia A.
Awasthi, Rakesh
Quintas-Cardama, Alfonso
Han, Xia
Maude, Shannon L.
Grupp, Stephan A.
Porter, David L.
Frey, Noelle
Marcucci, Katherine T.
Levine, Bruce L.
Melenhorst, Jan J.
June, Carl H.
Lacey, Simon F.
BLOOD, 2016, 128 (22)
[7] Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Relapsed/Refractory (R/R) CLL
Porter, David L.
Lacey, Simon F.
Hwang, Wei-Ting
Shaw, Pamela
Frey, Noelle V.
Chew, Anne
Chen, Fang
Kalos, Michael
Gonzalez, Vanessa
Marcucci, Katherine T.
Maude, Shannon L.
Melenhorst, Jan J.
Litchman, Manuel
Teachey, David T.
Shen, Angela
Quintas-Cardamas, Alfonso
Wood, Patricia A.
Levine, Bruce L.
June, Carl H.
Grupp, Stephan A.
BLOOD, 2014, 124 (21)
[8] CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T (CTL019) CELLS IN PEDIATRIC ALL: IMMUNE ACTIVATION SYNDROMES AND DURABLE RESPONSE
Barrett, David
Kalos, Michael
Teachey, David
Levine, Bruce
Rheingold, Susan
Aplenc, Richard
Porter, David
June, Carl
Grupp, Stephan
PEDIATRIC BLOOD & CANCER, 2013, 60 : S1 - S1
[9] Chimeric Antigen Receptor T Cells Directed Against CD19 Induce Durable Responses and Transient Cytokine Release Syndrome in Relapsed, Refractory CLL and ALL
Porter, David L.
Grupp, Stephan A.
Kalos, Michael
Loren, Alison W.
Lledo, Lester
Gilmore, Joan
Milone, Michael C.
Chew, Anne
Levine, Bruce L.
June, Carl H.
BLOOD, 2012, 120 (21)
[10] CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS DIRECTED AGAINST CD19 (CTL019) INDUCE CLINICAL RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY CD19+LYMPHOMAS
Levine, B.
Svoboda, J.
Nasta, S. D.
Porter, D.
Chong, E.
Lacey, S.
Mahnke, Y.
Melenhorst, J.
Chew, A.
Shah, G.
Hasskar, J.
Wasik, M.
Landsburg, D.
Mato, A.
Garfall, A.
Frey, N.
Shaw, P.
Marcucci, K.
Shea, J.
McConville, H.
Manvar, N.
O'Rourke, M.
Lamontagne, A.
Bersenev, A.
Zheng, Z.
Schuster, S.
June, C.
CYTOTHERAPY, 2015, 17 (06) : S13 - S13

← 1 2 3 4 5 →